Publication | Closed Access

Preoperative neoadjuvant targeted therapy remodels intra-tumoral heterogeneity of clear-cell renal cell carcinoma and ferroptosis inhibition induces resistance progression

UrologySurgical OncologyGenitourinary CancerKidney ResearchMedicinePathologyImmune Checkpoint InhibitorCancer TreatmentOncologyTumor MicroenvironmentTumor BiologyPreoperative Neoadjuvant